• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼表脆弱指数预测白内障手术后眼表症状的发生。

The Ocular Surface Frailty Index as a Predictor of Ocular Surface Symptom Onset after Cataract Surgery.

机构信息

Department of Clinical Sciences and Community Health, University of Milan, Eye Clinic San Giuseppe Hospital, IRCCS Multimedica, Milan, Italy.

Department of Clinical Sciences and Community Health, University of Milan, Eye Clinic San Giuseppe Hospital, IRCCS Multimedica, Milan, Italy.

出版信息

Ophthalmology. 2020 Jul;127(7):866-873. doi: 10.1016/j.ophtha.2019.12.012. Epub 2019 Dec 28.

DOI:10.1016/j.ophtha.2019.12.012
PMID:31964510
Abstract

PURPOSE

The identification of healthy persons more susceptible to dry eye (DED) symptoms developing after surgery remains an unmet need. We performed this study to build a new Ocular Surface Frailty Index (OSFI) and assess its predictive value for DED symptom onset after cataract surgery.

DESIGN

Single-center, observational, longitudinal study.

PARTICIPANTS

We screened 405 consecutive patients scheduled for phacoemulsification for age-related cataract. Two hundred eighty-four eyes of 284 patients without preoperative DED symptoms who underwent uneventful cataract surgery were included in the analysis.

METHODS

We built a tool to assess ocular surface frailty. Starting from a preliminary list of 19 potential items, the final OSFI, including 10 deficits in ocular surface health, factors potentially able to affect it, or both, was developed by a stepwise approach. Preoperative OSFI results were calculated for each enrolled patient and diagnostic tests for DED were performed at the screening visit and 1 week, 1 month, and 3 months after surgery. We evaluated the ability of OSFI to predict the presence of DED symptoms at 1 month or 3 months after surgery, or both.

MAIN OUTCOME MEASURES

The rate of ocular surface symptoms at 1 month or 3 months after surgery, or both.

RESULTS

Our patients' OSFI scores ranged from 0 to 0.666, with a median value of 0.200. The percentage of patients with postsurgical ocular surface symptoms was 17%. Using an OSFI cutoff of 0.300, we identified a small group (19% of the asymptomatic patients) with frail ocular surfaces who showed a significantly higher risk of postsurgical DED symptoms develop (50.0% vs. 9.6%; P < 0.001, chi-square test). Logistic regression analysis showed that OSFI results of 0.3 or more (but not age, gender, or any preoperative sign) was a good predictor of ocular surface symptom onset (odds ratio, 9.45; 95% confidence interval, 4.74-18.82). Regression remained significant when performed on 200 bootstrapped samples.

CONCLUSIONS

The OSFI can be calculated easily and quickly using noninvasive and low-tech procedures, and it proved to be predictive of postoperative DED symptoms onset. This novel tool may allow cataract surgeons to perform a useful preoperative personalized risk assessment.

摘要

目的

识别更易出现术后干眼(DED)症状的健康人群仍然是一项未满足的需求。我们进行了这项研究,以建立一个新的眼表脆弱指数(OSFI),并评估其对白内障手术后 DED 症状发作的预测价值。

设计

单中心、观察性、纵向研究。

参与者

我们筛选了 405 例计划行超声乳化白内障吸除术的连续患者。纳入分析的是 284 例无术前 DED 症状且无手术并发症的患者的 284 只眼。

方法

我们建立了一种评估眼表脆弱性的工具。从一个初步的 19 个潜在项目清单开始,通过逐步方法开发了一个包括 10 个眼表健康缺陷、可能影响其的因素或两者兼有的最终 OSFI。为每位入组患者计算术前 OSFI 结果,并在筛选就诊时以及术后 1 周、1 个月和 3 个月进行 DED 诊断测试。我们评估了 OSFI 预测术后 1 个月或 3 个月或两者均出现 DED 症状的能力。

主要观察指标

术后 1 个月或 3 个月或两者均出现眼表症状的发生率。

结果

我们患者的 OSFI 评分范围为 0 至 0.666,中位数为 0.200。术后出现眼表症状的患者比例为 17%。使用 OSFI 截断值 0.300,我们发现一小部分(无症状患者的 19%)眼表脆弱的患者出现术后 DED 症状的风险显著更高(50.0% vs. 9.6%;P < 0.001,卡方检验)。Logistic 回归分析显示,OSFI 结果为 0.3 或更高(但不包括年龄、性别或任何术前体征)是眼表症状发作的良好预测因素(优势比,9.45;95%置信区间,4.74-18.82)。在对 200 个 bootstrap 样本进行回归分析时,结果仍然显著。

结论

OSFI 可以使用非侵入性和低技术程序轻松快速地计算,并且已被证明可以预测术后 DED 症状的发作。这种新工具可能使白内障外科医生能够进行有用的术前个体化风险评估。

相似文献

1
The Ocular Surface Frailty Index as a Predictor of Ocular Surface Symptom Onset after Cataract Surgery.眼表脆弱指数预测白内障手术后眼表症状的发生。
Ophthalmology. 2020 Jul;127(7):866-873. doi: 10.1016/j.ophtha.2019.12.012. Epub 2019 Dec 28.
2
Bridging the gap in managing dry eye disease: a consensus report by the Taiwan society of cataract and refractive surgeons.解决干眼管理中的差距:白内障与屈光手术医师台湾学会的共识报告。
BMC Ophthalmol. 2024 Jul 29;24(1):314. doi: 10.1186/s12886-024-03565-9.
3
Understanding and Optimizing Ocular Biometry for Cataract Surgery in Dry Eye Disease: A Review.理解和优化干眼疾病白内障手术中的眼生物测量:综述。
Semin Ophthalmol. 2023 Jan;38(1):24-30. doi: 10.1080/08820538.2022.2112699. Epub 2022 Aug 20.
4
Management of dry eye disease to optimize cataract surgery outcomes: Two tables for a daily clinical practice.优化白内障手术效果的干眼疾病管理:日常临床实践的两张表格
J Fr Ophtalmol. 2019 Oct;42(8):907-912. doi: 10.1016/j.jfo.2019.03.032. Epub 2019 Jul 24.
5
Evaluation of dry eye after femtosecond laser-assisted cataract surgery.飞秒激光辅助白内障手术后干眼的评估
J Cataract Refract Surg. 2015 Dec;41(12):2614-23. doi: 10.1016/j.jcrs.2015.06.036.
6
Long-term Natural History of Dry Eye Disease from the Patient's Perspective.从患者角度看干眼症的长期自然史
Ophthalmology. 2016 Feb;123(2):425-433. doi: 10.1016/j.ophtha.2015.10.011. Epub 2015 Nov 21.
7
Management of cataract in dry eye disease: Preferred practice pattern guidelines.干眼病性白内障的管理:优先实践模式指南。
Indian J Ophthalmol. 2023 Apr;71(4):1364-1372. doi: 10.4103/IJO.IJO_2807_22.
8
Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.3% 四水二喹法索对干眼症患者白内障手术后结膜表面及临床结果的影响
Int Ophthalmol. 2018 Oct;38(5):2021-2030. doi: 10.1007/s10792-017-0693-1. Epub 2017 Aug 18.
9
Cataract surgery and dry eye disease: A review.白内障手术与干眼症:综述
Eur J Ophthalmol. 2020 Sep;30(5):840-855. doi: 10.1177/1120672120929958. Epub 2020 Jun 9.
10
Dry Eye Symptoms, Patient-Reported Visual Functioning, and Health Anxiety Influencing Patient Satisfaction After Cataract Surgery.干眼症状、患者报告的视觉功能以及健康焦虑对白内障手术后患者满意度的影响。
Curr Eye Res. 2017 Jun;42(6):832-836. doi: 10.1080/02713683.2016.1262429. Epub 2017 Jan 27.

引用本文的文献

1
Dry eye and systemic diseases.干眼与全身性疾病。
Saudi J Ophthalmol. 2025 Jan 2;39(1):5-13. doi: 10.4103/sjopt.sjopt_182_24. eCollection 2025 Jan-Mar.
2
Role of postoperative lubrication in preventing dry eye after cataract surgery in high- and low-risk patients stratified by ocular surface frailty index.根据眼表脆弱指数分层的高风险和低风险患者中,术后润滑在预防白内障手术后干眼方面的作用。
PLoS One. 2025 Mar 26;20(3):e0312712. doi: 10.1371/journal.pone.0312712. eCollection 2025.
3
Postoperative dry eye following femtosecond laser-assisted cataract surgery: insights and preventive strategies.
飞秒激光辅助白内障手术后的干眼:见解与预防策略
Front Med (Lausanne). 2024 Nov 18;11:1443769. doi: 10.3389/fmed.2024.1443769. eCollection 2024.
4
Preventing and Managing Iatrogenic Dry Eye Disease during the Entire Surgical Pathway: A Study Focusing on Patients Undergoing Cataract Surgery.在整个手术过程中预防和管理医源性干眼疾病:一项针对白内障手术患者的研究
J Clin Med. 2024 Jan 27;13(3):748. doi: 10.3390/jcm13030748.
5
Association of age-related eye diseases with cognitive frailty in older adults: a population-based study.与老年人年龄相关眼病与认知衰弱的关联:一项基于人群的研究。
Aging Clin Exp Res. 2023 Aug;35(8):1731-1740. doi: 10.1007/s40520-023-02458-z. Epub 2023 Jun 3.
6
Management of cataract in dry eye disease: Preferred practice pattern guidelines.干眼病性白内障的管理:优先实践模式指南。
Indian J Ophthalmol. 2023 Apr;71(4):1364-1372. doi: 10.4103/IJO.IJO_2807_22.
7
Evaluation of the effect of gentamicin in surgical perfusion solution on cataract postoperative endophthalmitis.评价术式灌洗液中庆大霉素对白内障术后眼内炎的疗效。
BMC Ophthalmol. 2022 Oct 23;22(1):410. doi: 10.1186/s12886-022-02633-2.
8
Presbyopia: An outstanding and global opportunity for early detection of pre-frailty and frailty states.老花眼:早期检测衰弱前期和衰弱状态的一个显著且全球性的契机。
Front Med (Lausanne). 2022 Oct 4;9:968262. doi: 10.3389/fmed.2022.968262. eCollection 2022.
9
Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta-Analysis.白内障手术后干眼疾病的患病率及特征:一项系统评价和Meta分析
Ophthalmol Ther. 2022 Aug;11(4):1309-1332. doi: 10.1007/s40123-022-00513-y. Epub 2022 May 9.
10
Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial.双氯非腙钠 3%与透明质酸 0.1%治疗白内障术后干眼的临床疗效比较:一项单中心、随机对照试验方案。
BMJ Open. 2022 Jan 31;12(1):e052488. doi: 10.1136/bmjopen-2021-052488.